Esperion Snags $125M Deal With Daiichi On Cholesterol Drug

By Gianna Ferrarin · January 3, 2024, 7:52 PM EST

Esperion Therapeutics Inc. on Wednesday announced a $125 million deal with a Japanese pharmaceutical giant to resolve Esperion's demand for $300 million from the company over Esperion's cholesterol reduction drugs....

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Case Information

Case Title

Esperion Therapeutics, Inc. v. Daiichi Sankyo Europe GmbH

Case Number

1:23-cv-02568

Court

New York Southern

Nature of Suit

Negotiable Instrument

Date Filed

March 27, 2023